Based on our results, BCL-2 did not show any association with ER, PR, and HER2, and its expression correlation demonstrated that BCL-2 was independent of grade, subtype, tumor size, and LN and its prognostic effects require further investigation. The gene discussed is ESR1; the disease is neoplasm.